Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03263403

Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.

A Randomized Observer-blinded Controlled Non-inferiority Trial to Evaluate the Immunogenicity of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladeshi Healthy Adults.

Sponsor: Incepta Vaccine Limited

Conditions Meningococcal Vaccine

Interventions Ingovax ACWY Quadri Meningo

Updated 6 times since 2017 Last updated: Mar 21, 2018 Started: Aug 21, 2017 Primary completion: Mar 19, 2018 Completion: Mar 19, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Meningococcal Vaccine and is currently completed. Incepta Vaccine Limited leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Apr 2018 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Sep 2017 — Apr 2018 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Incepta Vaccine Limited
International Centre for Diarrhoeal Disease Research, Bangladesh

Data source: International Centre for Diarrhoeal Disease Research, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh